• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌治疗后的体重增加和淋巴水肿:避免两难境地?

Weight Gain and Lymphedema After Breast Cancer Treatment: Avoiding the Catch-22?

机构信息

ICON Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia.

Australian Lymphoedema Education Research and Treatment (ALERT), Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.

出版信息

Lymphat Res Biol. 2022 Aug;20(4):409-416. doi: 10.1089/lrb.2020.0048. Epub 2021 Nov 8.

DOI:10.1089/lrb.2020.0048
PMID:34748426
Abstract

Overweight and obesity are strongly implicated in breast cancer (BC) development and are also a risk factor for BC-related lymphedema (BCRL). An online cross-sectional survey was conducted between November 2017 and January 2018. Analyses were restricted to women with localized BC, who provided information about BCRL ( = 238). Most women were not experiencing BCRL (55.46%). Mean self-reported weight at diagnosis was 68.55 kg for women without BCRL and 74.43 kg for women with BCRL ( = 0.0021). In this study, 50.9% with BCRL were overweight/obese at diagnosis (body mass index [BMI] ≥25) compared with 36.4% of women without BCRL ( = 0.003). For women without BCRL, 12.12% were classified as obese (BMI ≥30) versus 20.75% with BCRL. Women with BCRL were more likely to have gained >5% of body weight ( = 0.03), be currently overweight or obese ( = 0.004), and less active (48.11%) than they were at diagnosis than women without BCRL (33.33%) ( = 0.042). Having a structured exercise program, following a prescribed diet, and being accountable to someone else were identified as the main facilitators to successful weight loss and weight maintenance. Clinicians should consider obesity when personalizing axillary treatment and encourage lifestyle interventions and lymphedema screening after BC treatment.

摘要

超重和肥胖与乳腺癌(BC)的发生密切相关,也是乳腺癌相关淋巴水肿(BCRL)的一个危险因素。本研究于 2017 年 11 月至 2018 年 1 月期间开展了一项在线横断面调查。分析仅限于局部 BC 女性,她们提供了有关 BCRL 的信息( = 238)。大多数女性未发生 BCRL(55.46%)。无 BCRL 女性诊断时的平均自我报告体重为 68.55 kg,有 BCRL 女性为 74.43 kg( = 0.0021)。在本研究中,50.9%有 BCRL 的女性在诊断时超重/肥胖(BMI≥25),而无 BCRL 的女性为 36.4%( = 0.003)。无 BCRL 的女性中,12.12%被归类为肥胖(BMI≥30),而有 BCRL 的女性为 20.75%。与无 BCRL 的女性相比,有 BCRL 的女性更有可能体重增加>5%( = 0.03)、目前超重或肥胖( = 0.004),且活动量较少(48.11%),而不是诊断时的状态(33.33%)( = 0.042)。有结构化的锻炼计划、遵循规定的饮食和对他人负责被确定为成功减肥和保持体重的主要促进因素。临床医生在制定腋窝治疗方案时应考虑肥胖问题,并在 BC 治疗后鼓励进行生活方式干预和淋巴水肿筛查。

相似文献

1
Weight Gain and Lymphedema After Breast Cancer Treatment: Avoiding the Catch-22?乳腺癌治疗后的体重增加和淋巴水肿:避免两难境地?
Lymphat Res Biol. 2022 Aug;20(4):409-416. doi: 10.1089/lrb.2020.0048. Epub 2021 Nov 8.
2
Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.定义乳腺癌相关淋巴水肿(BCRL)的患病率和风险因素:淋巴水肿监测的实用方法。
Ann Acad Med Singap. 2024 Feb 28;53(2):80-89. doi: 10.47102/annals-acadmedsg.2023264.
3
Time trend of breast cancer-related lymphedema according to body mass index.根据体重指数的乳腺癌相关淋巴水肿的时间趋势。
Eur J Surg Oncol. 2024 Jun;50(6):108350. doi: 10.1016/j.ejso.2024.108350. Epub 2024 Apr 16.
4
Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.应用生物电阻抗分析检测乳腺癌幸存者淋巴水肿:一项前瞻性横断面研究。
BMC Cancer. 2019 Jul 8;19(1):669. doi: 10.1186/s12885-019-5840-9.
5
BE-WEL trial (breast: evaluation of weight and exercise for lymphoedema) testing weight control and exercise programmes for women with breast cancer related lymphoedema: a feasibility trial.BE-WEL 试验(乳房:体重评估和运动治疗淋巴水肿)测试针对乳腺癌相关淋巴水肿妇女的体重控制和运动方案:一项可行性试验。
Breast Cancer Res Treat. 2024 Aug;207(1):203-212. doi: 10.1007/s10549-024-07356-0. Epub 2024 May 17.
6
The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.监测技术对慢性乳腺癌相关淋巴水肿进展的影响:一项比较生物电阻抗光谱法与周径测量法的荟萃分析
Breast Cancer Res Treat. 2021 Feb;185(3):709-740. doi: 10.1007/s10549-020-05988-6. Epub 2020 Nov 27.
7
Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.乳腺癌相关性淋巴水肿的危险因素分析及预测模型的构建与评价。
Lymphat Res Biol. 2023 Dec;21(6):565-573. doi: 10.1089/lrb.2022.0058. Epub 2023 Sep 28.
8
Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.评估一家社区医院中与乳腺癌相关的淋巴水肿筛查和治疗差距。
J Surg Oncol. 2024 Aug;130(2):204-209. doi: 10.1002/jso.27735. Epub 2024 Jun 14.
9
Weight loss does not decrease risk of breast cancer-related arm lymphedema.体重减轻并不能降低乳腺癌相关上肢淋巴水肿的风险。
Cancer. 2021 Nov 1;127(21):3939-3945. doi: 10.1002/cncr.33819. Epub 2021 Jul 27.
10
Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.体重指数增加术后6至18个月患乳腺癌相关淋巴水肿的风险:一项回顾性研究。
Support Care Cancer. 2023 Apr 19;31(5):278. doi: 10.1007/s00520-023-07721-7.

引用本文的文献

1
The impact of obesity on the outcomes of complex decongestive therapy among patients with breast cancer-related lymphedema.肥胖对乳腺癌相关淋巴水肿患者复杂消肿治疗效果的影响。
Turk J Phys Med Rehabil. 2025 Feb 14;71(1):48-55. doi: 10.5606/tftrd.2025.15576. eCollection 2025 Mar.
2
Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.腋窝治疗与慢性乳腺癌相关淋巴水肿:前瞻性监测和干预的随机对照试验的影响。
JCO Oncol Pract. 2023 Dec;19(12):1116-1124. doi: 10.1200/OP.23.00060. Epub 2023 Oct 10.
3
The lymphatic vascular system: much more than just a sewer.
淋巴血管系统:远不止是一个下水道。
Cell Biosci. 2022 Sep 15;12(1):157. doi: 10.1186/s13578-022-00898-0.